
Daroo Darman Parmis (DDP) is a healthcare investment company in Iran, active in the pharmaceutical and medical device sectors. Although DDP has 9 years of corporate experience, its oldest subsidiary has been serving the Iranian healthcare market for nearly 50 years. The group currently comprises 9 subsidiaries, providing a strong and reliable foundation to pursue a forward-looking vision aimed at improving healthcare standards across the country.
Through strategic investments, operational guidance, and comprehensive support, DDP empowers its subsidiaries to grow, innovate, and deliver better solutions for patients and healthcare professionals. Our approach ensures that our portfolio companies can develop sustainably while meeting the evolving needs of the healthcare sector.
Our team actively collaborates with key industry associations and regulatory bodies to stay aligned with the latest regulations and market trends. Guided by the principles of integrity, innovation, and long-term planning, DDP supports its subsidiaries in achieving excellence and making a meaningful impact on healthcare outcomes for the people of Iran.
Daroo Darman Parmis (DDP) is a healthcare investment company in Iran, active in the pharmaceutical and medical device sectors. Although DDP has 9 years of corporate experience, its oldest subsidiary has been serving the Iranian healthcare market for nearly 50 years. The group currently comprises 9 subsidiaries, providing a strong and reliable foundation to pursue a forward-looking vision aimed at improving healthcare standards across the country.
Through strategic investments, operational guidance, and comprehensive support, DDP empowers its subsidiaries to grow, innovate, and deliver better solutions for patients and healthcare professionals. Our approach ensures that our portfolio companies can develop sustainably while meeting the evolving needs of the healthcare sector.
Our team actively collaborates with key industry associations and regulatory bodies to stay aligned with the latest regulations and market trends. Guided by the principles of integrity, innovation, and long-term planning, DDP supports its subsidiaries in achieving excellence and making a meaningful impact on healthcare outcomes for the people of Iran.
Daroo Darman Parmis (DDP) is a leading healthcare investment group in Iran, active in the import, production, and distribution of medical devices, pharmaceuticals and Nutraceuticals. Formally established in 2016, DDP now
oversees a network of several high-performing subsidiaries.
We take pride in our
subsidiaries, each of which makes significant contributions to the healthcare
industry. Recognized as leaders in their respective fields, they continually
set benchmarks for excellence and innovation.
Together, our subsidiaries form a robust ecosystem that drives growth, fosters innovation, and ensures the consistent delivery of world-class healthcare solutions across Iran.
Our Subsidieries:
At Daroo Darman Parmis, we are staunch advocates for local manufacturing, boasting state-of-the-art facilities that produce high-quality medical devices, dietary supplements, and pharmaceuticals.
Medical Device Facility
Covering 6,000 m² and certified to GMP and ISO standards, this facility manufactures a wide range of products, including surgical sutures, wound dressings, surgical mesh, catheters, and guidewires for cardiology and urology. It includes 400 m² of ISO Class 7 and 400 m² of ISO Class 8 cleanrooms, along with an advanced quality control laboratory equipped for physical, chemical, and microbial testing.
Teams of engineers and technicians continuously refine processes to deliver innovative solutions and ensure patient safety.
Facility Areas
Teams of engineers and technicians continuously refine processes to deliver innovative solutions and ensure patient safety.
Pharmaceutical Facility
Among the subsidiaries of the holding, the largest production site of Daroo Darman Parmis (DDP) occupies 8,400 m² of land with a 13,000 m² built-up area, making it one of the most significant production and distribution centers within Iran’s healthcare network.
The facility operates under a robust quality framework that ensures safety, efficacy, and full regulatory compliance. Continuous process improvements drive growth in product portfolios and enhance patient outcomes. Through its manufacturing subsidiaries, DDP remains dedicated to elevating healthcare standards and fostering innovation.
Through our investment in domestic production, while benefiting all stakeholders, we aim to:
Facility Areas
Through its strategic subsidiaries, DDP continues to play a key role in advancing healthcare standards and driving innovation across Iran.
Daroo Darman Parmis (DDP) is a leading Iranian holding company engaged in
the import, manufacturing, and distribution of medical devices,
pharmaceuticals, and nutraceuticals across all 31 provinces of Iran.
The holding employs 500 staff members, including 60 professionals in
sales and marketing teams. Leveraging partnerships with renowned brands,
DDP’s subsidiaries adhere to GMP and ISO standards while delivering
high-quality products.
By combining strict quality controls, strategic alliances, and a
commitment to ongoing education, DDP has established itself as a trusted
partner in the healthcare sector, dedicated to raising healthcare standards
and providing comprehensive, reliable solutions for clients throughout Iran.
Leveraging OFAC clearance and strong collaborations with companies
around the world, including partners from the U.S., Europe, and Asia,
DDP brings world-class products and raw materials into Iran’s healthcare
market.
DDP’s extensive product portfolio includes a wide range of categories, such
as disposable and hospital-based medical devices, vascular access, cardiac care,
airway management, surgery, wound care, mother-and-baby products, as well
as pharmaceuticals and dietary supplements.
By focusing on strategic logistics, innovation, and exceptional customer
service, DDP has become a trusted supplier in Iran’s healthcare
sector. With a mission to elevate healthcare standards through long-term
partnerships and value-driven solutions, DDP continuously expands its global
network. The company’s vision is centered on delivering sustainable
innovations that reduce the burden on customers while enabling better
outcomes for healthcare providers and patients.
Proven Excellence: Our
extensive experience in the medical and pharmaceutical industries underscores
our commitment to quality and reliability.
Comprehensive Investment and Support: We offer robust investment and support services to all our
subsidiaries,enabling them to thrive and innovate.
Strategic Partnerships: We
maintain strong alliances with leading international brands, ensuring access to
cutting-edge medical technologies and products.
Focus on Domestic Manufacturing: We are dedicated to enhancing national economic growth through domestic
manufacturing initiatives.
Expanded Distribution Network: Our extensive and reliable distribution network spans the country,
ensuring timely and effective delivery of healthcare solutions.
Commitment to Innovation, Quality, and Trust: Our core principles drive everything we do, guiding us in shaping a future focused on excellence and integrity.
At Daroo Darman Parmis (DDP), our distribution strategy focuses on delivering healthcare products efficiently and reliably across Iran:
Efficient Logistics: Using advanced systems to ensure timely and safe deliveries.
Expanding Reach: Extending our network to cover both major cities and underserved regions.
Strategic Partnerships: Collaborating with external companies to offer a wider range of products.
Reliable Service: Aiming to be the preferred partner, recognized for speed, dependability, and excellence.
Through this approach, DDP ensures that patients and healthcare professionals have consistent access to the products they need.
At Daroo Darman Parmis, we acknowledge that research and development (R&D) is the cornerstone of innovation. We are committed to:
The establishment of the main member of DDP Group, “IranPharmis”
Importing the first disposable medical products: sterile hypodermic needles.
Beginning a partnership with a Japanese company to import medical adhesives
Starting cooperation with a Danish company to import ostomy products
Introducing advanced wound care dressings to the Iranian Market for the first time
Expanding our activities by establishing a new company focusing on general medical equipment
Construction of our first production facility to produce surgical sutures and wound dressings.
Acquiring several small businesses, active in healthcare sector
Buying major shares of a newly established pharmaceutical company and stepping into pharmaceutical industry
Signing a contract with an Irish company to import ostomy products
Beginning a cooperation with an American company to import top-notch examination and surgical gloves
Some companies of the group gained ISO9001 and ISO13485
Adding vascular access and hemodialysis catheters from Arrow to our portfolio through a cooperation with Teleflex
Import of professional urology, surgical, and anesthesia-respiratory products
Establishment of a pharmaceutical company and presenting dietary supplements
Daroo Darman Parmis Company was officially formed as the main owner of the Holding
Acquiring a new company with focus on import of home-care, maternal and pediatric medical products.
Starting the construction of our new facility in two phases to produce general and hazardous solid pharmaceuticals and dietary supplements
The Pharmaceutical company started its production and introduced its first products to the market